Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PODD Insulet

Trading 12-22 15:20:25 EST

291.42

+1.80

+0.62%

High292.53	Low287.97	Vol343.73K
Open289.82	D1 Closing289.62	Amplitude1.57%
Mkt Cap20.50B	Tradable Cap20.42B	Total Shares70.35M
T/O99.56M	T/O Rate0.49%	Tradable Shares70.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"Insulet","latestPrice":291.42,"timestamp":1766434824393,"preClose":289.62,"halted":0,"volume":343727,"delay":0,"floatShares":70078499,"shares":70346898,"eps":3.450812,"marketStatus":"Trading","change":1.8,"latestTime":"12-22 15:20:25 EST","open":289.82,"high":292.53,"low":287.97,"amount":99555489.94945,"amplitude":0.015745,"askPrice":291.76,"askSize":112,"bidPrice":291.39,"bidSize":171,"shortable":3,"etf":0,"ttmEps":3.450812,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":289.62,"preHourTrading":{"tag":"盘前","latestPrice":294.69,"preClose":289.62,"latestTime":"09:25 EST","volume":41700,"amount":12077317.881,"timestamp":1766413500061},"postHourTrading":{"tag":"盘后","latestPrice":289.1,"preClose":289.62,"latestTime":"18:07 EST","volume":83544,"amount":24197980.86,"timestamp":1766185630601},"volumeRatio":0.435192,"impliedVol":0.3686,"impliedVolPercentile":0.276},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"2593439161","title":"Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593439161","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593439161?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:16","pubTimestamp":1766409389,"startTime":"0","endTime":"0","summary":"If you are looking at Insulet and wondering whether the recent price makes it a buy, hold, or avoid, you are not alone. This stock often divides opinion among growth focused investors.\nAfter a strong run to around $289.62, the shares are still up 12.8% year to date and 10.0% over the last year, even though the stock has slipped 0.6% in the past week and 12.5% over the past month and remains roughly flat over 3 years while still compounding at 13.2% over 5 years.\nRecent attention has centred...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/is-insulet-fairly-priced-after-its-strong-run-and-high-earni","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/is-insulet-fairly-priced-after-its-strong-run-and-high-earni","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PODD"],"gpt_icon":0},{"id":"2592478197","title":"Insulet Discloses Remediated IT Control Weakness in Financial Reporting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592478197","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592478197?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:07","pubTimestamp":1766178469,"startTime":"0","endTime":"0","summary":"Insulet Corporation previously disclosed a material weakness in its internal controls related to ineffective information technology general controls around systems supporting the company’s financial reporting outside of North America. The company reported that this material weakness has since been remediated. There were no other reportable events or disagreements with its former auditor, Grant Thornton LLP, during the fiscal years 2023 and 2024 and the interim period through December 15, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL4s1NL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4551","LU2065170008.USD","LU1119994496.HKD","BK4566","LU2065171311.SGD","BK4588","BK4585","LU1084165304.USD","BK4082","LU1261432733.SGD","PODD","LU2065169927.USD","LU0728928796.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2592182635","title":"Insulet Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2592182635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592182635?lang=en_us&edition=fundamental","pubTime":"2025-12-19 06:07","pubTimestamp":1766095620,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Insulet Corp.  rose 1.14% to $292.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85.This was the stock's second consecutive day of gains.Insulet Corp. closed 17.47% below its 52-week high of $354.88, which the company reached on November 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co.  rose 1.45% to $1,056.88, DexCom Inc.  rose 0.24% to $65.91, and Johnson & Johnson  fell 0.96% to $208.31.Trading volume  eclipsed its 50-day average volume of 658,783.Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491050071.SGD","IE00BJLML261.HKD","BK4599","IE00BKDWB100.SGD","LU2063271972.USD","LU2237438978.USD","IE00BK4W5L77.USD","LU0006306889.USD","LU1804176565.USD","LU0985320562.USD","LU2361044949.HKD","SG9999013999.USD","IE00BLSP4452.SGD","LU2746668974.SGD","LU0353189680.USD","LU1814569148.SGD","LU2471134523.USD","LU2505996509.AUD","LU2237443465.HKD","IE00BVYPNW00.USD","LU0708995401.HKD","BK4550","LU0823416689.USD","LU2361044865.SGD","LU0256863811.USD","LU1366192091.USD","LU1720051108.HKD","SG9999001440.SGD","LU1261432733.SGD","LU1548497426.USD","LU1066051811.HKD","LU2106854487.HKD","LU2430703251.USD","LU0320765646.SGD","SG9999001176.USD","LU1267930730.SGD","LU1585245621.USD","LU0820561909.HKD","SG9999014880.SGD","SG9999015952.SGD","LU2265009873.SGD","LU2264538146.SGD","LU1623119135.USD","LU0203202063.USD","LU1732799900.SGD","LU0320765992.SGD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","LU2065171311.SGD","IE0009355771.USD","IE00B3T34201.USD","LU1244550577.SGD","LU2461242641.AUD","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","LU0266013472.USD","IE00BWXC8680.SGD","LU0256863902.USD","LU0456855351.SGD","LU2237443895.HKD","LU2168564065.EUR","LU1093756168.USD","LU1064131342.USD","LU2456880835.USD","BK4559","LU0096364046.USD","LU2133065610.SGD","BK4516","IE00BKVL7J92.USD","LU0203201768.USD","LU1032955483.USD","SG9999018857.SGD","LU0417517546.SGD","LU0823434740.USD","LU0728928796.USD","IE00BDGV0183.EUR","LU1093756325.SGD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1291159041.SGD","LU0345769128.USD","LU2552382215.SGD","IE00BSNM7G36.USD","LU0124676726.USD","LU2462157665.USD","LU0106261372.USD","BK4007","LU2129689514.USD","LU0792757196.USD","LU1868836914.USD","LU1894683264.USD","LU2592432038.USD","SG9999014898.SGD","LU1551013342.USD","BK4566","LU1551013425.SGD","LU2552382132.HKD","LU1032466523.USD","LU0354030511.USD","LU2168564149.EUR","IE00B1XK9C88.USD","LU2087625088.SGD","IE00BJJMRY28.SGD","SGXZ57979304.SGD","LU2168564222.USD","LU2237443549.SGD","LU1059921491.USD","LU1232071149.USD","LU2125909247.SGD","LU0198837287.USD","LU0471298777.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU0070217475.USD","SG9999015945.SGD","IE00BN29S564.USD","SG9999002224.SGD","LU0640476718.USD","LU2491050154.USD","IE00BVYPNV92.GBP","LU0466842654.USD","LU2023250504.SGD","IE00BGHQF631.EUR","LU1720051017.SGD","LU1923622614.USD","LU0345770308.USD","GB00BDT5M118.USD","LU2112291526.USD","LU2417539215.USD","LU1974910355.USD","LU0289739699.SGD","LU0787776722.HKD","IE00B4JS1V06.HKD","IE0002141913.USD","LU2433249047.HKD","IE00B3PB1722.GBP","LU1221951129.SGD","IE00B7SZLL34.SGD","LU0912757837.SGD","LU2505996681.GBP","IE00BMPRXR70.SGD","LU0320765059.SGD","LU0471298694.HKD","LU1196500208.SGD","LU2108987350.USD","LU0683600562.USD","LU2168563687.JPY","LU2552382058.USD","LU2065169927.USD","IE00BFXG1179.USD","BK4533","IE00BJT1NW94.SGD","LU1280957306.USD","LU2468319806.SGD","BK4585","SGXZ51526630.SGD","IE00BFSS8Q28.SGD","LU2430703095.HKD","LU1935042991.SGD","SG9999018865.SGD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU0889566641.SGD","IE00BJJMRX11.SGD","LU1929549753.HKD","IE00BFSS7M15.SGD","BK4568","BK4592","LU1778281490.HKD","SG9999014906.USD","LU1989771016.USD","LU2125909593.SGD","IE0004445239.USD","LU1983299246.USD","LU0795875086.SGD","LU1061106388.HKD","BK4082","IE00BBT3K403.USD","LU2236285917.USD","SG9999017495.SGD","LU0345769631.USD","LU2750360641.GBP","LU0689626769.HKD","LU1988902786.USD","LU1868837136.USD","LU0345770993.USD","LU1868836757.USD","LU1066053197.SGD","LU0109394709.USD","LU0114720955.EUR","IE0002270589.USD","LU0823434583.USD","LU2347655156.SGD","SGXZ99366536.SGD","BK4532","LU2129689605.HKD","LU0882574139.USD","LU1074936037.SGD","BK4588","LU2746668461.USD","LU0109391861.USD","IE00B775H168.HKD","LU0203347892.USD","LU2065170008.USD","LU2237443382.USD","BK4534","LU2237443978.SGD","LU2357305700.SGD","LU2430703178.SGD","LU0820561818.USD","IE0034235303.USD","LU2602419157.SGD","LU0079474960.USD","LU0353189763.USD","LU2360106947.USD","BK4504","LU2211815571.USD","LU0316494557.USD","LU0203345920.USD","LU1732800096.USD","IE00B2B36J28.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU1267930813.SGD","IE00B42XCP33.USD","LU1084165304.USD","LU1162221912.USD","LU1718418525.SGD","LU1244550221.USD","LU2237443622.USD","LU1496350502.SGD","IE00BK4W5M84.HKD","LU1712237335.SGD","LU2324357040.USD","LU1066051225.USD","LU1506573853.SGD","IE00BMPRXN33.USD","LU2168564495.EUR","LU0385154629.USD","LU1674673691.USD","LU1023059063.AUD","SG9999014914.USD","LU1057294990.SGD","SGXZ31699556.SGD","LU2471134952.CNY","LU1244550494.USD","BK4548","LU0058720904.USD","LU1914381329.SGD","LU0097036916.USD","LU0672654240.SGD","LU2089984988.USD","LU2471134796.USD","LU0354030438.USD","LU0432979614.USD","LU0234572021.USD","LU1119994496.HKD","IE0005OL40V9.USD","LU0943347566.SGD","LU0889565916.HKD","LU1069344957.HKD","LU2129689431.USD","PODD","LU0795875169.SGD","LU0689472784.USD","LU1868837300.USD","SG9999002232.USD","IE00BKPKM429.USD","LU2361045086.USD","SG9999001176.SGD","LU2491049909.HKD","SG9999015986.USD","LU1868836591.USD","LU0122379950.USD","LU0098860793.USD","LU0882574055.USD","LU2750360997.AUD","LU2065171402.SGD","LU1127390331.HKD","LU0094547139.USD","LU0786609619.USD","BK4581","LU1221951046.USD","BK4551","LU2471134879.HKD","LU0238689110.USD","LU1035775433.USD","LU1674673428.USD","LU1917777945.USD","LU1894683348.USD","LU1323610961.USD","IE0004445015.USD","IE00B7KXQ091.USD","LU1066051498.USD","SG9999015978.USD","LU0323591593.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2592902193","title":"Truist Securities Lowers Price Target on Insulet to $390 From $412, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902193","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592902193?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:47","pubTimestamp":1766069240,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average rating of buy and mean price target of $381.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2592943654","title":"Insulet Updates Annual Incentive Plan With Expanded Eligibility and Higher Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2592943654","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592943654?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:03","pubTimestamp":1766005410,"startTime":"0","endTime":"0","summary":"Insulet Corporation has approved an amended and restated Annual Incentive Plan, effective January 1, 2026. Key changes to the plan include a clarified definition of \"for Cause\" termination, expanded eligibility for prorated annual award payments following retirement if certain age and service requirements are met, and broadened eligibility for award payments in cases of termination \"without Cause.\" The plan also increases the maximum award available to participants and includes additional clarifying language.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2PkY8v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","BK4588","BK4551","LU1261432733.SGD","LU2065170008.USD","LU2065171402.SGD","BK4082","LU1084165304.USD","LU0728928796.USD","PODD","BK4585","BK4566","LU2324357040.USD","LU2065171311.SGD","LU1119994496.HKD"],"gpt_icon":0},{"id":"2592660948","title":"Insulet Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592660948","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592660948?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:16","pubTimestamp":1766002560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 15:16 ET (20:16 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2592994445","title":"Canaccord Genuity Adjusts Price Target on Insulet to $450 From $432, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994445","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994445?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:54","pubTimestamp":1765972441,"startTime":"0","endTime":"0","summary":"Canaccord Genuity Adjusts Price Target on Insulet to $450 From $432, Maintains Buy Rating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2592937610","title":"Insulet Corporation Director Wayne A.I. Frederick Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937610","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592937610?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:04","pubTimestamp":1765919081,"startTime":"0","endTime":"0","summary":"Wayne A.I. Frederick, Director, reported a disposal of common shares of Insulet Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL2k7mR4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Insulet Corporation Director Wayne A.I. Frederick Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU2065169927.USD","LU0728928796.USD","LU1261432733.SGD","LU2065170008.USD","BK4082","LU2324357040.USD","LU1084165304.USD","BK4585","LU2065171311.SGD","LU2065171402.SGD","PODD","BK4566","BK4588","LU1119994496.HKD"],"gpt_icon":0},{"id":"2591980527","title":"Insulet Initiated at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980527","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591980527?lang=en_us&edition=fundamental","pubTime":"2025-12-16 22:08","pubTimestamp":1765894080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 16, 2025 09:08 ET (14:08 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2591981307","title":"Evercore ISI Initiates Coverage on Insulet With Outperform Rating, $370 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981307","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981307?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:17","pubTimestamp":1765887429,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average rating of Buy and mean price target of $381.52, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2591989283","title":"Insulet Corporation to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989283","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591989283?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:01","pubTimestamp":1765886473,"startTime":"0","endTime":"0","summary":"Insulet Corporation, the global leader in tubeless insulin pump technology, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 11:15 a.m. Pacific Time. The live webcast and replay of the presentation will be available on the Insulet Investor Relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via Business Wire  on December 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL3TBSMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0728928796.USD","LU2324357040.USD","BK4585","LU1084165304.USD","LU2065171402.SGD","LU2065170008.USD","PODD","LU1261432733.SGD","LU2065171311.SGD","BK4588","LU1119994496.HKD","BK4566","BK4551","LU2065169927.USD"],"gpt_icon":0},{"id":"2591986258","title":"BUZZ-Insulet gets 'outperform' rating as Evercore starts coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2591986258","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591986258?lang=en_us&edition=fundamental","pubTime":"2025-12-16 19:35","pubTimestamp":1765884942,"startTime":"0","endTime":"0","summary":"BUZZ-Insulet gets 'outperform' rating as Evercore starts coverage** Brokerage Evercore ISI starts coverage on insulin device maker Insulet PODD.O with \"outperform\" rating and a PT of $370 ** PT repres","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nL6N3XM0O2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU1084165304.USD","LU1119994496.HKD","LU2065169927.USD","BK4551","LU2065171402.SGD","BK4588","LU0728928796.USD","LU2065171311.SGD","LU2324357040.USD","LU1261432733.SGD","BK4585","PODD","LU2065170008.USD","BK4566"],"gpt_icon":0},{"id":"2591781985","title":"Insulet Corp : Evercore Isi Initiates Coverage With Outperform Rating; Target Price $370","url":"https://stock-news.laohu8.com/highlight/detail?id=2591781985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591781985?lang=en_us&edition=fundamental","pubTime":"2025-12-16 19:03","pubTimestamp":1765883001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1261432733.SGD","LU2065169927.USD","BK4588","LU2065171402.SGD","PODD","LU2324357040.USD","LU2065171311.SGD","BK4551","BK4585","LU0728928796.USD","LU1084165304.USD","LU2065170008.USD","LU1119994496.HKD","BK4566","BK4082"],"gpt_icon":0},{"id":"2591622235","title":"Insulet Corp. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622235","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591622235?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:07","pubTimestamp":1765836420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Insulet Corp.  slid 1.42% to $291.51 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.16% to 6,816.51 and Dow Jones Industrial Average  falling 0.09% to 48,416.56.Insulet Corp. closed 17.86% short of its 52-week high of $354.88, which the company achieved on November 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co.  rose 3.38% to $1,062.19, DexCom Inc.  fell 1.84% to $65.73, and Johnson & Johnson  rose 1.22% to $214.17.Trading volume  eclipsed its 50-day average volume of 643,014.Data source: Dow Jones Market Data, FactSet. Data compiled December 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2591645300","title":"Insulet Expands Omnipod Recycling Program Nationwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2591645300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591645300?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:00","pubTimestamp":1765800054,"startTime":"0","endTime":"0","summary":"Insulet Corporation has announced the nationwide expansion of its Pod recycling program in the United States. The program, previously piloted in Massachusetts and California, allows U.S. customers to request a recycling kit online at no cost and return used Omnipod insulin pump Pods for recycling. The returned devices are decontaminated and sent to a company specializing in recycling electronics and medical products. Insulet also operates Pod takeback programs in several international markets. The initiative is part of the company's efforts to reduce landfill waste and support more sustainable product life cycles.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL9gFSf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","PODD","BK4585","LU2065171402.SGD","LU1084165304.USD","LU2065170008.USD","LU1261432733.SGD","LU2065169927.USD","BK4566","LU2065171311.SGD","LU2324357040.USD","BK4588","BK4082","LU1119994496.HKD","LU0728928796.USD"],"gpt_icon":0},{"id":"2590365668","title":"Director Timothy C. Stonesifer Acquires Common Shares of Insulet Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590365668","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590365668?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:03","pubTimestamp":1765227812,"startTime":"0","endTime":"0","summary":"Timothy C. Stonesifer, Director, reported an acquisition of common shares of Insulet Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL9pJ0Kt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Timothy C. Stonesifer Acquires Common Shares of Insulet Corporation","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0728928796.USD","LU1119994496.HKD","PODD","LU1084165304.USD","LU2324357040.USD","BK4585","BK4588","BK4551","LU2065170008.USD","LU2065169927.USD","LU2065171402.SGD","LU2065171311.SGD","LU1261432733.SGD","BK4566","BK4082"],"gpt_icon":0},{"id":"2589335615","title":"Insulet Names Cristal Downing Chief Corporate Affairs Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2589335615","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589335615?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:04","pubTimestamp":1765202669,"startTime":"0","endTime":"0","summary":"Insulet Corporation has appointed Cristal Downing as Chief Corporate Affairs Officer, a newly created role. Downing will lead the company's Global Communications, Public Policy, Government Affairs, and Corporate Reputation & Stakeholder Engagement functions, reporting to President and CEO Ashley McEvoy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief on December 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL4j153N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1084165304.USD","LU2065169927.USD","LU2065171402.SGD","BK4082","LU1261432733.SGD","PODD","LU2324357040.USD","LU2065171311.SGD","BK4551","LU0728928796.USD","BK4566","LU1119994496.HKD","BK4585","LU2065170008.USD","BK4588"],"gpt_icon":0},{"id":"2589858315","title":"Insulet Corp. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2589858315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589858315?lang=en_us&edition=fundamental","pubTime":"2025-12-05 06:08","pubTimestamp":1764886080,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Insulet Corp.  rose 2.72% to $315.92 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.11% to 6,857.12 and the Dow Jones Industrial Average  falling 0.07% to 47,850.94.The stock's rise snapped a three-day losing streak.Insulet Corp. closed 10.98% short of its 52-week high of $354.88, which the company reached on November 20th.The stock outperformed some of its competitors Thursday, as Eli Lilly & Co.  fell 1.85% to $1,014.49, DexCom Inc.  rose 0.62% to $65.25, and Johnson & Johnson  fell 1.39% to $202.48.Trading volume  eclipsed its 50-day average volume of 651,120.Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2588889656","title":"Insulet Wins FDA Clearance for Enhanced Omnipod 5 Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889656","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588889656?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:00","pubTimestamp":1764849638,"startTime":"0","endTime":"0","summary":"Insulet Corporation has received FDA 510 clearance for significant enhancements to its Omnipod 5 Automated Insulin Delivery System. The newly approved updates include a lower 100 mg/dL target glucose option and improvements to the system's automated experience, enabling users to stay in Automated Mode with fewer interruptions. These advancements are expected to launch in the United States in the first half of 2026, further simplifying insulin delivery and improving clinical outcomes for people with diabetes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via Business Wire  on December 04, 2025, and is solely responsible for the information contained the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL9gNF04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1084165304.USD","LU2065169927.USD","LU2065171402.SGD","BK4082","LU1261432733.SGD","PODD","LU2324357040.USD","LU2065171311.SGD","BK4551","LU0728928796.USD","BK4566","LU1119994496.HKD","BK4585","LU2065170008.USD","BK4588"],"gpt_icon":0},{"id":"2588889673","title":"Insulet Corp - Omnipod 5 Algorithm Updates to Launch in U.S. in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588889673?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:00","pubTimestamp":1764849601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUABCYXZY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","LU2065170008.USD","BK4082","BK4551","LU1261432733.SGD","LU2065169927.USD","BK4585","PODD","LU2065171402.SGD","BK4566","LU1119994496.HKD","LU2324357040.USD","BK4588","LU0728928796.USD","LU1084165304.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":-0.1638},{"period":"3month","weight":-0.1246},{"period":"6month","weight":-0.0446},{"period":"1year","weight":0.1289},{"period":"ytd","weight":0.1094}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":-0.000513},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.008002},{"month":3,"riseRate":0.666667,"avgChangeRate":0.008437},{"month":4,"riseRate":0.444444,"avgChangeRate":0.018608},{"month":5,"riseRate":0.444444,"avgChangeRate":0.026797},{"month":6,"riseRate":0.789474,"avgChangeRate":0.048531},{"month":7,"riseRate":0.368421,"avgChangeRate":-0.014587},{"month":8,"riseRate":0.789474,"avgChangeRate":0.073949},{"month":9,"riseRate":0.526316,"avgChangeRate":0.010557},{"month":10,"riseRate":0.526316,"avgChangeRate":-0.010123},{"month":11,"riseRate":0.684211,"avgChangeRate":0.083141},{"month":12,"riseRate":0.421053,"avgChangeRate":0.031574}],"exchange":"NASDAQ","name":"Insulet","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Insulet,PODD,Insulet股票,Insulet股票老虎,Insulet股票老虎国际,Insulet行情,Insulet股票行情,Insulet股价,Insulet股市,Insulet股票价格,Insulet股票交易,Insulet股票购买,Insulet股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction